The human glycoprotein hormone ot-subunit gene is expressed in two quite dissimilar tissues, the placenta and anterior pituitary. Tissue-specific expression is determined by combinations of elements, some ofwhich are common and others of which are specific to each tissue. In the placenta, a composite enhancer confers specific expression. It contains four protein-binding sites: two cyclic AMP (cAMP) response elements that bind CREB, a trophoblast-specific element that binds TSEB, and a sequence motif, AGATAA, that matches the consensus binding site for a family of transcription factors termed the GATA-binding proteins. In pituitary gonadotropes, the cAMP response elements remain important for expression, TSEB is absent, and elements further upstream participate in tissue-specific expression. Here we establish a regulatory role for the GATA element in both the placenta and pituitary by demonstrating that a mutation of this element decreases ot-subunit gene expression 15-fold in JEG-3 human placental cells and 2.5-fold in otT3-1 mouse pituitary gonadotropes. In JEG-3 cells, human GATA-2 (hGATA-2) and hGATA-3 are highly expressed and both proteins bind to the ot-subunit gene GATA element. In otT3-1 cells, the GATA motif is bound by mouse GATA-2 (mGATA-2) and an mGATA-4-related protein. Cotransfection of hGATA-2 or hGATA-3 into otT3-1 cells activates the ft-subunit gene threefold. These studies establish a role for the GATA-binding proteins in placental and pituitary ft-subunit gene expression, significantly expanding the known target genes of GATA-2, GATA-3, and perhaps GATA-4.
The profile of genes distinguishing an individual differentiated cell type is determined by specific transcriptional regulatory proteins expressed in highly restricted patterns (38, 43) . First identified as controlling erythroid cell-specific transcription of the chicken 3-globin gene cluster, members of the family of transcriptional regulators called the GATA-binding proteins (45) bind to a GATA core motif within the broader consensus sequence WGATAR (W indicates T or A, and R indicates G or A). This sequence is present in the regulatory regions of many genes, including most erythroid cell-specific genes (17) . Members of the GATA-binding protein family contain two copies of a unique, highly conserved zinc finger domain of the form C-X-N-C-X17-C-N-X-C (39), which is involved in DNA binding.
Presently, the family of vertebrate GATA-binding proteins is composed of four proteins designated GATA-1 (16, 59) , (64) , (64) , and GATA-4 (3, 31) , each of which has a distinct tissue distribution and developmental profile. GATA-1 is expressed only in cells of hematopoietic lineages, specifically erythroid cells, mast cells, and megakaryocytes, and it activates many, if not all, erythroid cell-specific genes (17, 40, 60) . GATA-1 plays an obligate role in erythroid cell differentiation since embryonic stem cells harboring a mutant GATA-1 gene fail to contribute to erythroid lineage in chimeric mice (47) . GATA-2 is expressed in many different tissues and cell types, including erythroid, fibroblast, and endothelial cells (14, 36, 64) . This protein activates an endothelial cell-specific gene, the preproendothelin-1 gene (62) . In chickens, expression is restricted to adult reticulocytes, T lymphocytes, the embryonic brain, and the adult kidney (64) . Human GATA-3 regulates the T-cell receptor genes in T lymphocytes and has been proposed to play a role in regulating the development of the T-cell lineage (23, 30, 34) . Lastly, two distinct factors, both termed GATA-4 (one from mice and the other from Xenopus laevis), are expressed in a restricted set of tissues including the heart, intestinal epithelium, primitive endoderm, and gonads (3, 31) .
Our initial interest in the GATA-binding family of proteins stemmed from studies directed at determining the mechanisms controlling tissue-specific expression of the glycoprotein hormone a.-subunit gene in different species (54) . The ot-subunit gene of the glycoprotein hormones is a single-copy gene expressed in the pituitary of all mammals as a component of luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone (19, 21) , but it is known to be expressed only in the placenta of primate and equine species (7, 20) . Humans and horses express this gene in the placenta as a component of human chorionic gonadotropin and pregnant mare serum gonadotropin, respectively. Within the placenta, expression of the at-subunit gene is specifically directed to trophoblast cells, while in the pituitary, expression is specifically directed to gonadotropes and thyrotropes.
The molecular basis for placenta-specific expression of the human and equine a-subunit genes has been studied by transfection of human placental trophoblast cell lines that express human chorionic gonadotropin (10, 54) . The human gene contains a composite enhancer, positioned within 180 bp of the mRNA start site, that confers placental specificity. At least two distinct cis-acting regulatory sequences compose the enhancer, a cyclic AMP (cAMP) response element (CRE) and a trophoblast-specific element (TSE; also called the upstream regulatory element [URE]) (11, 28, 29) . Present as an exact 18-bp direct repeat (12, 53) , the two copies of the CRE each bind the ubiquitous protein CREB (22, 24) . The TSE is located 30 bp upstream of the CREs and binds TSEB, a protein specific to the placenta (11, 55) . In contrast, the equine Instead, placental specificity is controlled by two GATA elements that bind a factor we originally designated at-ACT (54) . The upstream (AGATAA) and downstream (TGATAA) equine a-ACT binding sites display exact homology to the GATA consensus sequence, indicating that at-ACT may be a member of the GATA-binding family of proteins. The equine upstream GATA element is perfectly conserved in the human at-subunit gene and positioned within the placenta-specific enhancer between the TSE and CREs. Thus, in addition to controlling equine at-subunit gene expression, ao-ACT is likely to regulate transcription of the human gene as well.
Control of cell-specific expression of the at-subunit gene in the pituitary differs from that in the placenta (5, 25) . As (25) or in thyrotrope tumor cells when it is deleted from the mouse gene (44) . Other regions of the mouse gene have also been implicated in activity in thyrotropes (-480 to -417, -254 to -177, and -177 to -120) (44) and gonadotropes (-445 to -438) (51) .
A regulatory role for the human a-subunit gene GATA element was investigated by introducing point mutations into this element, as well as into the binding sites for CREB and TSEB, and analyzing the effect of each mutation on a-subunit gene expression by transfection into the placental cell line, JEG-3, and the pituitary gonadotrope cell line, aT3-1 (63) . We found that a mutation of the a-subunit gene GATA element decreases transcriptional activity 15-fold in placental cells and 2.5-fold in pituitary gonadotrope cells. Thus, maximal activity of the placenta-specific enhancer requires not only a functional CRE and TSE but the GATA element as well. Furthermore, in JEG-3 cells, the a-subunit gene GATA element is bound by both human GATA-2 (hGATA-2) and hGATA-3, while in pituitary gonadotropes, it is bound by mouse GATA-2 (mGATA-2) and an mGATA-4-related protein, revealing that the GATA-binding family of transcription factors is involved in specific expression of the gonadotropin a-subunit gene in the placenta and pituitary.
MATERUILS AND METHODS
Plasmid constructions. The a-subunit gene enhancer mutants were constructed from the plasmid pa224ACAT. This vector contains the ao-subunit gene sequence from -224 to +60 cloned into the XbaI and XhoI sites of pTKCAT (54) so that the thymidine kinase promoter sequence is replaced with the a-subunit gene enhancer/promoter. pa224ACAT contains only one copy of the two 18-bp CRE repeats and was constructed by digesting pa224CAT (11) Relative CAT Activity The DNA sequence of the placenta-specific enhancer of the human a-subunit gene is presented with the CRE, TSE, and GATA core motifs shown in boldface. The 18-bp duplicated CRE directly downstream of -129 is not shown since it has been specifically removed from all reporter genes used for these studies. The single-base mutations introduced into the human a-subunit gene are shown above the DNA sequence and incorporate the equine and murine base substitutions within the core regulatory elements as well as several additional substitutions to further disrupt the DNA sequence. (B) DNase I protection analysis of protein binding to the CRE, TSE, and GATA sites within the ox-subunit gene enhancer. 32P-end-labeled ox-subunit gene fragments containing the mutations described in panel A were incubated with 15 and 0 pg of JEG-3 nuclear extract, partially digested with DNase I, and separated on a 6% sequencing gel. Point mutations within the CRE (C), TSE (T), and GATA element (G) for probe DNAs are indicated for each binding reaction. Protected regions are indicated by rectangular boxes. (C) Transfection of a-subunit genes with wild-type and mutant enhancers into JEG-3 cells. CAT expression plasmids were constructed containing the human a-subunit gene from -224 to +60 (with one of the two 18-bp CRE repeats deleted) with either wild-type or mutant CREs, TSEs, and GATA elements. The transcriptional activity of each mutated regulatory element along with different combinations of mutated elements was compared with the activity of the intact a-subunit enhancer by transfection into the placental trophoblast cell line JEG-3. The presence of a wild-type CRE, TSE, and GATA element in each transfected plasmid is indicated by a triangle, oval, and diamond, respectively. CAT activity values are corrected for levels of ,B-galactosidase activity from an internal control ,B-galactosidase expression vector and normalized to the activity of the wild-type oa-subunit gene promoter. Values are the means of three independent transfection experiments, with error bars representing the standard errors of the means. digested with BamHI, and then digested with Klenow fragment to fill in the 5' overhang. The hGATA-3 protein coding sequence was produced by amplifying JEG-3 first-strand cDNA by using PCR with primers targeted to the N-and C-terminal ends of hGATA-3. Primers contained XbaI sites on their 5' ends to facilitate cloning into the XbaI site of pEVFR2 and incorporated single amino acid substitutions at the Nterminal (leucine substituted for methionine) and C-terminal (glycine replaced with valine) ends. The entire hGATA-3 fragment generated by PCR was sequenced to confirm that no mutations were created by Taq DNA polymerase during amplification.
Cell culture, transfections, and CAT assays. JEG-3 cells were maintained in Dulbecco modified Eagle medium supplemented with 5% fetal bovine serum, 5% equine serum, 4.5 mg of glucose per ml, penicillin (100 U/ml), and streptomycin (0.1 mg/ml). otT3-1 cells were maintained in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum, 4.5 mg of glucose per ml, penicillin (100 U/ml), and streptomycin (0.1 mg/ml). (9), incubated for5 h, and rinsed before the media were changed. Cells were harvested after 48 h. CAT assays were performed as previously described (52) , and,B-galactosidase assays were performed as described elsewhere (11) . Units of CAT activity were normalized to the 3-galactosidase activity of the internal control.
Oligonucleotides. For DNA binding studies, oligonucleotides were purified on acrylamide gels before use. Doublestranded DNA oligonucleotides corresponding to the following regions in the human ot-subunit gene were used: TSE, from -180 to -157 bp, and GATA, from -162 to -142 bp. Both oligonucleotides contain 5' GATC 3' at their 5' ends.
Isolation and characterization of hGATA-3 cDNAs. Approximately 5 ng of JEG-3 poly(A)+ RNA and primers homologous to regions within the highly conserved zinc finger domain of the GATA-binding proteins were used in PCR to amplify putative GATA-binding factors in JEG-3 cells. The sense primer encodes the amino acids ECVNCGA, positioned within the amino-terminal zinc finger of hGATA-2 and hGATA-3, and it is a 20-mer with full degeneracy (256-fold) to represent all possible codon uses. The antisense primer encodes HN(V/I)NRPL, an amino acid sequence carboxy terminal to the second zinc finger domain in hGATA-2 and hGATA-3, and it is also a fully degenerate 20-mer (4,096-fold degeneracy). Following PCR, the expected 278-bp fragment was gel isolated and blunt-end cloned into the EcoRV site of Bluescript KS(+) (Stratagene). Dideoxy DNA sequencing (48) revealed that the PCR product is identical to hGATA-3. A X-Zap (Stratagene) cDNA library prepared from JEG-3 poly(A)+ RNA was screened under high-stringency hybridization to the hGATA-3 zinc finger domain. Hybridizations were carried out for 24 (3, 000 Ci/mmol), redigesting with XhoI, and lastly gel isolating the -300-bp fragments.
DNase I protection was performed with 5,000 to 10,000 cpm (i.e., -1 to 2 fmol) of probe per binding reaction as previously described (54) .
Gel retardation assays. The gel retardation assay was slightly modified from that of Sawadogo et al. (50) (6, 000 Ci/mmol). All binding reactions were carried out at room temperature, and each reaction mixture was preincubated 5 to 10 min before the addition of the probe (10,000 cpm, 1 to 2 fmol). To resolve complexes, the reaction mixtures were applied to 5% native acrylamide gels (30:1 ratio of acrylamide to bisacrylamide) in 0.25 x Trisborate-EDTA-5% (vol/vol) glycerol.
RESULTS
The GATA motif present in the human a-subunit gene enhancer confers enhanced transcriptional activity in placental cells. To firmly establish a role for the GATA element in expression of the human a-subunit gene, single-base substitutions were introduced into the placenta-specific enhancer to specifically prevent the binding of CREB, TSEB, and ax-ACT proteins. We designed the point mutations on the basis of the findings that none of these proteins bind to the analogous region of the murine at-subunit gene and that neither CREB nor TSEB binds to the equine gene (54) (Fig. 1A) . Thus, comparison of the CRE, TSE, and GATA sequences in the human at-subunit gene to homologous regions in the murine and equine genes provides critical sequence information concerning the binding requirements for CREB, TSEB, and a.-ACT. The murine and equine genes both have an identical, single-base substitution (i.e., a thymine substituted for a cytosine) in the fourth position of the core CRE sequence (TGATGTCA) that abolishes CREB binding. Similarly, the TSE core sequence, CCNNNGGG, determined by methylation interference studies with the human a-subunit TSE (27, 55) , contains distinct and overlapping point mutations in the murine (TCT£jAGGG) and equine (TCTAAGAG) genes that abolish TSEB binding. Lastly, the binding of ao-ACT to the murine gene is prevented by a single-base substitution in the GATA analogous region of this gene (TGATAT) that disrupts the WGATAR consensus motif.
Though the binding sites are very closely spaced, all three proteins bind simultaneously to the a-subunit gene in vitro (54) . To demonstrate that these mutations eliminate binding to individual elements without affecting binding of the adjacent proteins, we used ax promoter DNA fragments containing these mutations as probes in DNase I protection studies with nuclear protein extract from JEG-3 cells, a human placental trophoblast cell line that produces both the at-and ,3-subunits of CG (35) . Incubation of 15 jig of extract with DNA probes containing individual mutations, followed by partial digestion with DNase I, revealed that each of the three mutations effectively eliminates binding (Fig. IB) . Furthermore, the removal of (Fig. 1C) . As expected, a mutation of either the CRE or TSE decreased ao-subunit gene transcription, the magnitude of the reduction being approximately 12-and 2.5-fold, respectively. However, transcriptional activity decreased 15-fold because of the mutation in the GATA motif, demonstrating a strong contribution by this element to a-subunit gene expression. Additionally, the removal of more than one factor-binding site reduced expression even further. Transcriptional activity declined more than 20-fold compared with that of the intact at enhancer region for those reporter genes containing a single functional CRE, TSE, or GATA element. When all sites within the placenta-specific enhancer were destroyed, expression decreased approximately 90-fold, confirming the importance of the enhancer region in ao-subunit gene activity. Furthermore, these data demonstrate that the three elements interact synergistically by activating a-subunit gene transcription to a level much greater than that predicted by adding the levels of expression produced by the individual regulatory elements.
The GATA-3 and GATA-2 genes are expressed in JEG-3 cells. Because of the sequence homology between the GATA element in the a-subunit enhancer and the consensus GATA motif, we hypothesized that a-ACT might be a member of the GATA-binding family of proteins. Methylation interference data obtained for GATA-2 (62) revealed that this factor contacts the core GATA motif (AGATAA; base pairs contacted are underlined). Methylation interference analysis on the ao-subunit enhancer GATA element with JEG-3 nuclear extract demonstrated that all the nucleotides which completely interfered with binding when methylated are located within the consensus GATA sequence in a pattern of protein-DNA contacts identical to that found for GATA-2 (data not shown), supporting the idea that a-ACT is a member of this family.
Since it was likely that at-ACT is a member of the GATAbinding protein family, we investigated whether this factor might be distinct from previously characterized GATA-binding proteins. Therefore, an approach directed at isolating a-ACT cDNA was taken. Degenerate oligonucleotides encoding regions of the highly conserved DNA-binding finger domain of the GATA-binding factors were designed and used for PCR (see Materials and Methods). Amplification of JEG-3 poly(A)+ RNA produced a DNA fragment encoding the GATA-binding protein finger domain. We subsequently isolated four overlapping cDNA clones from a JEG-3 cDNA library that specifically hybridize to the 278-bp PCR fragment. DNA sequence analysis demonstrated that all four cDNA clones were identical to hGATA-3.
GATA-3 expression patterns in chicken and murine tissues are similar in that the sites of most abundant expression are the embryonic brain and T lymphocytes (34, 64) . Interestingly, mGATA-3 mRNA has also been detected in the murine placenta (34) (Fig.  3B) . The addition of mGATA-2 antiserum to a binding reaction mixture containing the a-subunit gene GATA probe and JEG-3 nuclear extract eliminated the upper protein-DNA complex yet had no effect on the lower band. No change in either gel shift complex is observed with preimmune serum. The control lanes revealed that the antiserum blocked binding by hGATA-2 in the HeLa extract but had no effect on hGATA-3 binding in the Jurkat extract. In both of the JEG-3 MOL. CELL. BIOL. ,ug), HeLa (1 ,g), and Jurkat (1 ,ug) cells. As a specific competitor, unlabeled GATA oligonucleotide was added at an approximately 100-fold molar excess over the probe. (B) mGATA-2 antiserum identifies hGATA-2 as one of the two proteins binding to the a-subunit gene GATA element. Binding reactions were performed as described above except that, where indicated, 1 jil of either mGATA-2 antiserum or preimmune serum was added to the reaction mixture. In order to completely resolve the protein-DNA complexes, gel electrophoresis was carried out for an extended period, which resulted in the free probe migrating out of the gel. The arrowhead indicates a presumed supershift complex.
and HeLa binding reactions in which the mGATA-2 antiserum was used, a weak band positioned high in the gel is present. This complex may represent a supershift consisting of the DNA probe, hGATA-2, and mGATA-2 antibody, suggesting that hGATA-2 DNA binding is not completely blocked by mGATA-2 antiserum. We conclude from these studies that the upper gel shift complex yielded by the JEG-3 nuclear extract is produced by hGATA-2. Additionally, because the extension of time for this gel electrophoresis experiment allowed complete resolution of the protein-DNA complexes, it is clear that the lower JEG-3 mobility shift complex migrates identically to that produced by hGATA-3 in the Jurkat extract. Thus, given that hGATA-3 mRNA is present in JEG-3 cells, the lower complex very likely represents hGATA-3 binding to the probe.
Pituitary regulation of the human ae-subunit gene is mediated in part by the GATA motif. In addition to placental trophoblasts, the human a-subunit gene is also expressed in the gonadotrope and thyrotrope cells of the pituitary. Analysis of the cis-acting sequences downstream of -224 in the human a-subunit gene has revealed that pituitary gonadotrope regulation involves the CRE and the GSE positioned at -223 to -197 (25) . Interestingly, a truncation of the a gene sequence between the GSE and CREs, a region which contains the GATA motif, was shown to decrease reporter gene activity approximately twofold in aT3-1 cells (25) . Therefore, to determine whether the GATA element confers transcriptional activity to the a-subunit gene in the pituitary, the a-subunit reporter genes described in Fig. 1 were transfected into aT3-1 cells, a murine pituitary gonadotrope cell line expressing the endogenous a-subunit gene (63) . Specific mutation of the a-subunit gene GATA element decreased expression roughly 2.5-fold (Fig. 4) , a finding consistent with the truncation analysis. Mutation of the CRE, a known regulator of the human a-subunit gene in the pituitary (25, 51) , reduced activity approximately eightfold. When both the GATA element and CRE were mutated, reporter gene activity decreased approximately 18-fold, suggesting that these cis-acting sequences functionally interact and providing additional evidence that the GATA motif regulates transcription of the a-subunit gene in the pituitary.
Two GATA-binding proteins expressed in aT3-1 pituitary cells bind the a-subunit gene GATA element. To determine whether members of the GATA-binding family of transcription factors are expressed in aT3-1 cells, Northern analysis was performed on aT3-1 RNA with cDNAs of the murine GATAbinding proteins as hybridization probes. aT3-1 cells do not appear to contain mGATA-1 or mGATA-3, since mRNAs for these proteins were not detected in aT3-1 RNA (Fig. 5) . However, the hybridization of aT3-1 RNA with mGATA-2 cDNA produced a signal identical to that yielded with RNA from murine erythroleukemia cells, a hematopoietic cell line expressing the GATA-2 gene (64 Relative CAT Activity   FIG. 4 . Analysis of the transcriptional activity mediated by the a-subunit gene GATA motif in pituitary cells. The a-subunit reporter genes described in Fig. 1 were transfected into the pituitary cell line aT3-1. The presence of a wild-type CRE, TSE, and GATA element in each transfected plasmid is indicated by a triangle, oval, and diamond, respectively. CAT activity values are corrected for levels of ,-galactosidase activity from an internal control I-galactosidase expression vector and normalized to the activity of the wild-type a-subunit gene promoter. Values are the means of three independent transfection experiments, with errors bars representing the standard errors of the means. element, electrophoretic mobility shift analysis was performed with aT3-1 nuclear extract and with the human a gene GATA element as a probe. Though our original analysis of the expression of the ot-subunit gene in atT3-1 cells did not reveal a footprint over the GATA site (25) , the more sensitive technique of gel shift analysis detected two specific protein-DNA complexes with otT3-1 nuclear extract and the GATA GATA-1
Northern analysis of the murine GATA-binding proteins expressed in aT3-1 cells. Total RNA derived from JEG-3 (2 ,ug), oaT3-1 (10 jxg), F9 (10 ,ug) (treated for 96 h with 0.2 ,uM retinoic acid), and murine erythroleukemia (MEL) (5 ,ug) cells was hybridized to 32P-labeled cDNA probes encoding mGATA-1, mGATA-2, mGATA-3, and mGATA-4. MEL RNA serves as a positive control for mGATA-1 and mGATA-2 mRNAs, while mGATA-4 mRNA is induced by retinoic acid in mouse F9 cells (3) . In order to prevent cross-hybridization between the probe DNA and the highly conserved DNA-binding domains of the different GATA-binding proteins, all of the cDNA probes except for mGATA-4 did not contain the Zn finger domain.
probe (Fig. 6A) . These bands are specific since unlabeled GATA oligonucleotide added to the binding reaction mixture completely eliminated both shifted bands, whereas a heterologous competitor had no effect. Incubation of nuclear extract from retinoic acid-induced F9 cells with the GATA DNA probe produced a major protein-DNA complex, which likely corresponds to mGATA-4 bound to the DNA probe (3) , that migrated with the lower aT3-1 gel shift complex.
Because axT3-1 cells contain mGATA-2 mRNA, we investigated whether one of the two gel shift complexes generated with otT3-1 nuclear extract represents a complex of mGATA-2 and the GATA probe. Addition of the mGATA-2 antiserum described above (Fig. 3) to the electrophoretic mobility shift assays decreased the upper protein-DNA complex and produced a supershifted band positioned high in the gel (Fig. 6B) . Preimmune serum had no effect on the upper gel shift complex, indicating that this band corresponds to mGATA-2 bound to the DNA probe. When added to the binding reaction mixture containing F9 nuclear extract, mGATA-2 antiserum decreased the minor gel shift band and produced a very weak supershifted complex, which is not surprising since mGATA-2 mRNA is present in these cells (Fig. 5) . The properties of the presumptive mGATA-4-DNA complex from F9 nuclear extract were not affected by mGATA-2 antiserum, and this complex migrated identically to the lower gel shift complex from aT3-1 extract, providing additional evidence that a GATA-4-related factor is present in atT3-1 cells.
GATA-2 and GATA-3 trans activate expression from a human a-subunit reporter gene. The hypothesis that GATAbinding proteins transcriptionally regulate the human at-subunit gene also involves determining a functional role for these proteins in a gene expression. To (Fig.  7) . In aT3-1 cells, overexpression of hGATA-2 and hGATA-3 stimulated expression of the a-subunit reporter gene approximately five-and sixfold, respectively. However, the reporter gene carrying a mutant GATA motif exhibited twofold stimulation in response to the hGATA-2 and hGATA-3 expression vectors, an effect we believe to be nonspecific since these same expression vectors stimulated expression of the thymidine kinase promoter roughly twofold (data not shown). Therefore, overexpression of hGATA-2 and hGATA-3 specifically activated the ao-subunit gene enhancer/promoter in trans approximately 2.5-to 3-fold. In support of these studies, an expression plasmid producing mGATA-3 (34) also stimulated activity from the a-subunit reporter gene in aT3-1 cells threefold (data not shown). DISCUSSION The family of GATA-binding proteins is composed of multiple members, each expressed in a distinct spatial and developmental pattern (45) . Here we have established that this family of transcription factors is involved in placenta-and pituitary-specific gene expression. In the placental trophoblast cell line JEG-3, both hGATA-2 and hGATA-3 are expressed and bind to the human gonadotropin a-subunit gene GATA element and a mutation of this element decreases expression 15-fold. In aT3-1 pituitary gonadotrope cells, a mutation of the a-subunit gene GATA motif reduced transcriptional activity 2.5-fold and mGATA-2 and an mGATA-4-related protein were found to be expressed and to bind to this site. Furthermore, cotransfection of hGATA-2 or hGATA-3 into aT3-1 cells trans activated expression from an a-subunit reporter gene, demonstrating a functional role for members of the GATA-binding family of transcription factors in ax-subunit gene regulation. It is not surprising that both hGATA-2 and hGATA-3 activated the a-subunit gene, since several groups have shown that these proteins interchangeably activate genes containing GATA motifs in cotransfections (14, 30, 34, 64) . In contrast to the cotransfection studies with aT3-1 cells, cotransfection of hGATA-2 or hGATA-3 into JEG-3 cells did not activate the ax-subunit gene. Thus, it is likely that in JEG-3 cells, hGATA-2 and/or hGATA-3 endogenous levels are not limiting for transcriptional activation, so increasing the level of GATA-binding protein produced no increase in expression. In support of this idea, Fig. 4 reveals that hGATA-2 and hGATA-3 mRNAs are present at much higher levels in JEG-3 cells than in the control cell lines HeLa and Jurkat. Additionally, 2 jig of JEG-3 RNA hybridized to an mGATA-2 cDNA probe produced a significantly stronger signal than that yielded with 10 jig of aT3-1 RNA (Fig. 5) . The high levels of hGATA-2 and hGATA-3 mRNAs in JEG-3 cells also correlate with high protein levels since nuclear extracts derived from JEG-3 cells produced more abundant gel shift complexes than those from Jurkat, HeLa, and aT3-1 cells.
Identification of a specific activity for the GATA sequence element in the a-subunit gene allows clarification of the 1 and what may be assumed to be TSEB (termed band 2) cannot bind simultaneously (27) , while the GATA proteins and TSEB do bind simultaneously (54) . Third, the methylation interference patterns for band 1 (58) . Alternatively, the synergistic qualities of these elements may be conferred by proteinprotein contacts that increase the transcriptional activation properties of these factors. DNA binding assays combined with in vitro transcription analysis with highly purified proteins and defined nucleosomal templates will provide further insight into the molecular mechanisms controlling expression of the human a-subunit gene. Our studies demonstrate a new tissue-specific activity for hGATA-3. Although first shown to be present in adult reticulocytes, T lymphocytes, the embryonic brain, and the adult kidney (23, 30, 34, 64) , we found hGATA-3 to be abundantly expressed in JEG-3 human placental cells. Furthermore, GATA-3 (and/or GATA-2) binding to the GATA element in the a-subunit gene is required for the full activity of the composite placenta-specific enhancer. GATA-3 may also regulate the placental lactogen gene in rat placental cells (36a) and has been found in mouse placental RNA (34) , indicating a role for GATA-3 in activating multiple genes in placental trophoblast cells, analogous to its role in the hematopoietic cell lineages.
The presence in a single cell type of multiple members of a given transcription factor family with highly related DNAbinding specificities presents the problem of determining the mechanism of differential activation. The ability of proteins with the same DNA-binding specificity to direct distinct patterns of gene expression has been extensively studied in the case of mammalian POU homeodomain proteins Oct-1 and Oct-2. The ubiquitous Oct-1 and the related B cell protein Oct-2 differentially regulate gene expression through promoter-selective activation domains, which stimulate transcription from specific promoters containing octamer motifs (57) . For example, activation of the human U2 small nuclear RNA promoter is accomplished more effectively by Oct-1 than by Oct-2 (57), whereas Oct-2 activates the human P-globin promoter more effectively (32, 56 
